Palatin Technologies
PTN
#10225
Rank
C$37.25 M
Marketcap
C$20.94
Share price
5.76%
Change (1 day)
16,570.18%
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2025 (TTM): -C$6.94 Million

According to Palatin Technologies's latest financial reports the company's current earnings are C$8.84 Million. In 2024 the company made an earning of -C$37.02 Million, an increase over its 2023 earnings that were of -C$44.55 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$6.94 Million-81.27%
2024 -C$37.02 Million-16.9%
2023 -C$44.55 Million5.99%
2022 -C$42.03 Million-13.7%
2021 -C$48.7 Million33.25%
2020 -C$36.55 Million-172.11%
2019 C$50.67 M2352.33%
2018 C$2.06 M-94.13%
2017 C$35.21 M-154.92%
2016 -C$64.12 Million3.67%
2015 -C$61.85 Million878%
2014 -C$6.33 Million-72.64%
2013 -C$23.12 Million-33.11%
2012 -C$34.56 Million77.71%
2011 -C$19.45 Million
2003 -C$32.93 Million29.93%
2002 -C$25.34 Million36.18%
2001 -C$18.61 Million
1999 -C$15.45 Million6.04%
1998 -C$14.57 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$35.69 B-541,884.50%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$20.14 B-305,913.46%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
C$1.09 B-16,758.74%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-C$16.5 Million 150.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
C$0.22 B-3,513.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-C$0.17 Billion 2,353.60%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
C$0.13 B-2,097.69%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-C$40.52 Million 514.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-C$79.62 Million 1,108.36%๐Ÿ‡บ๐Ÿ‡ธ USA